Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07847008

Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth (Phase 2)

Conditions: Perceived Burdensomeness, Suicidal Ideation

Sex: All
Ages: 12 Years – 17 Years
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Florida International University

Location: FIU Center for Children and Families Miami Florida

Summary

This project embeds the "Give to Others" (GO) talk therapy module in a standard, outpatient therapy protocol to demonstrate target engagement in the context of ongoing clinical care and testing the ability of the GO module to engage the target in a rigorous randomized controlled trial (RCT) of the intervention. We will target perceived burdensomeness (PB) among 80 clinic-referred youths (ages 12-17) who experience subacute suicidal ideation (SI; i.e., positive suicide risk screen; stable safety status).

Eligibility Criteria

Inclusion Criteria Adolescents must: * be between ages 12 and 17 years * score at or above the clinical cutoff on the Revised Child Anxiety and Depression Scale * score at or above 4 on the Interpersonal Needs Questionnaire- Burdensomeness Scale * have a positive screen for suicide risk (i.e., endorsement of suicidal ideation via self-report) * be fluent in English and have available a parent who is fluent in English or Spanish Exclusion Criteria For adolescents to be excluded, they must: * have cognitive impairment or developmental delay which does not allow for the completion of basic study procedures (i.e., reading and filling out questionnaires; talking to a clinician) * show imminent risk or a history of hurting themselves or others requiring intensive and restrictive services * be involved currently in a psychosocial treatment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07847008). StuddyBuddy aggregates publicly available trial information.